Invitae Corporation
NVTA
Peringkat dalam Saham
#35748
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Harga Saham
$0.016
Terakhir disinkronkan: 2024-03-11
Kapitalisasi Pasar
$3.27M
Perubahan (1 hari)
-5.33%
Perubahan (1 tahun)
5,233.33%
Negara
US
Perdagangan Invitae Corporation (NVTA)
Kategori
Healthcare
Pendapatan untuk Invitae Corporation (NVTA)
Pendapatan pada Sep 2023 TTM: $481.58M
Menurut laporan keuangan terbaru dari Invitae Corporation, pendapatan saat ini (TTM) adalah $481.58M. Pada tahun 2022, perusahaan menghasilkan pendapatan sebesar $516.30M peningkatan dibandingkan pendapatan pada tahun 2021 yang sebesar $460.45M. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Invitae Corporation dari 2016 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $481.58M | -1.11% |
| 2023 | $487.00M | -5.68% |
| 2022 | $516.30M | 12.13% |
| 2021 | $460.45M | 64.68% |
| 2020 | $279.60M | 28.95% |
| 2019 | $216.82M | 46.80% |
| 2018 | $147.70M | 116.50% |
| 2017 | $68.22M | 172.36% |
| 2016 | $25.05M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $46.34B | 9,521.60% |
US
|
|
| $25.11B | 5,113.43% |
US
|
|
| $2.71B | 462.12% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 1,430.78% |
US
|
